Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · IEX Real-Time Price · USD
25.92
-0.76 (-2.85%)
Jun 14, 2024, 4:00 PM EDT - Market closed

Mirum Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019
Market Capitalization
1,2221,376719489449564
Market Cap Growth
-91.39%47.13%8.83%-20.35%-
Enterprise Value
1,2261,398610365268451
PE Ratio
-7.45-8.42-5.30-5.82-4.35-10.73
PS Ratio
5.457.389.3325.53--
PB Ratio
5.215.535.064.072.614.33
P/FCF Ratio
-53.57-19.37-5.97-19.72-5.03-14.22
P/OCF Ratio
-53.77-19.40-5.98-3.68-5.04-14.32
EV/Sales Ratio
5.477.507.9119.06--
EV/EBITDA Ratio
-9.33-10.29-4.98-5.58-2.62-8.63
EV/EBIT Ratio
-8.31-9.49-4.84-5.50-2.60-8.58
EV/FCF Ratio
-53.79-19.67-5.06-14.72-3.00-11.37
Debt / Equity Ratio
1.311.241.001.100.300.03
Debt / EBITDA Ratio
-2.42-2.27-1.16-2.03-0.50-0.07
Debt / FCF Ratio
-13.95-4.34-1.18-5.35-0.57-0.09
Quick Ratio
3.384.074.266.1012.568.92
Current Ratio
3.684.452.943.9112.809.13
Asset Turnover
0.370.360.240.0800
Interest Coverage
-9.88-9.75-7.89-3.77-307.25-
Return on Equity (ROE)
-76.30%-88.60%-102.20%-82.70%-70.70%-96.20%
Return on Assets (ROA)
-26.50%-31.50%-42.00%-33.60%-58.10%-45.60%
Return on Capital (ROIC)
-20.01%-19.60%-46.11%-68.61%-46.77%-40.85%
Earnings Yield
-12.98%-11.88%-18.87%-17.19%-23.00%-9.32%
FCF Yield
-1.80%-5.16%-16.75%-5.07%-19.89%-7.03%
Buyback Yield / Dilution
-24.56%-20.31%-12.07%-20.08%-119.84%-
Total Shareholder Return
-24.56%-20.31%-12.07%-20.08%-119.84%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).